Study on Indomethacin-responsive Headaches

NCT03967483 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2019-05-30

No results posted yet for this study

Summary

Description of modalities concerning the patient care of headaches sensible to indometacine.

Conditions

  • Headache, Migraine

Interventions

DRUG

Indometacin

patient who are taken indomatacin for headaches and migraine

Sponsors & Collaborators

  • Anne Ducros

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-01
Primary Completion
2020-06-01
Completion
2021-06-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03967483 on ClinicalTrials.gov